Analysis on drug resistance of mycobacterium tuberculosis in Fengxian district Shanghai
Zheng Hua-rong
Abstract
Zheng Hua-rong
Abstract
To understand primary and acquired drug resistance of mycobacterium tuberculosis. M.tuberculosis positive sputum samples were collected from January 2002 to July 2003. Ameliorative Lowenstein-Jensen' culture medium was used to detect bacillus-positive specimen of pulmonary tuberculosis. 214 samples were affirmed. Drug susceptibility test against streptomycin(SM), isoniazid (INH),rifampicin (RFP), ethambutol (EMB) and sodium para-aminosalicylate (PAS) were tested. The total drug resistance rate was 39.25% (84/214), the initial drug resistance rate was 11.83% (11/93), the initial multi-drug resistance rate was 7.53% (7/93), the acquired and multi-drug resistance(MDR) rate were 60.33% (73/121) .MDR-TB rate was 49.93% (58/121). SM and INH were primary and secondary resistance drugs, the rates were 75.00% (63/84) and 63.10% (53/84). [Conclusion] The acquired drug resistant and multi-drug resistant rates were higher than the initial drug resistance rate. Drug sensitivity surveillance on mycobacteria tuberculous should be further strengthened.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To understand primary and acquired drug resistance of mycobacterium tuberculosis. M.tuberculosis positive sputum samples were collected from January 2002 to July 2003. Ameliorative Lowenstein-Jensen' culture medium was used to detect bacillus-positive specimen of pulmonary tuberculosis. 214 samples were affirmed. Drug susceptibility test against streptomycin(SM), isoniazid (INH),rifampicin (RFP), ethambutol (EMB) and sodium para-aminosalicylate (PAS) were tested. The total drug resistance rate was 39.25% (84/214), the initial drug resistance rate was 11.83% (11/93), the initial multi-drug resistance rate was 7.53% (7/93), the acquired and multi-drug resistance(MDR) rate were 60.33% (73/121) .MDR-TB rate was 49.93% (58/121). SM and INH were primary and secondary resistance drugs, the rates were 75.00% (63/84) and 63.10% (53/84). [Conclusion] The acquired drug resistant and multi-drug resistant rates were higher than the initial drug resistance rate. Drug sensitivity surveillance on mycobacteria tuberculous should be further strengthened.
Key concepts: Ethambutol, Rifampicin, Drug resistance, Isoniazid, Streptomycin, Medicine, Mycobacterium tuberculosis, Tuberculosis